NCT02834988View on ClinicalTrials.gov

Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer

CompletedOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

July 28, 2016

Primary Completion Date

January 14, 2020

Study Completion Date

February 10, 2020

Conditions
Endometrial Cancer
Trial Locations (1)

33136

University of Miami, Miami

All Listed Sponsors
lead

University of Miami

OTHER

NCT02834988 - Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer | Biotech Hunter | Biotech Hunter